Opinion of Issuer’s Counsel. The Investor shall have received an opinion of Issuer’s counsel, dated the date of Closing, in the form attached hereto as Exhibit E.
Appears in 2 contracts
Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)
Opinion of Issuer’s Counsel. The Investor shall have received an opinion of Issuer’s counsel, dated the date of Closing, in the form attached hereto as Exhibit E.B.
Appears in 2 contracts
Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)
Opinion of Issuer’s Counsel. The Investor shall have received an opinion of Issuer’s counsel, dated the date of ClosingClosing Date, in the form attached hereto as Exhibit E.C.
Appears in 2 contracts
Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)
Opinion of Issuer’s Counsel. The Investor shall have received an opinion of Issuer’s counsel, dated the date of ClosingClosing Date, in the form attached hereto as Exhibit E.
Appears in 2 contracts
Samples: Subscription Agreement (Regen Biologics Inc), Subscription Agreement (Regen Biologics Inc)
Opinion of Issuer’s Counsel. The Investor shall have received an opinion of Issuer’s counsel, dated the date of ClosingClosing Date, in the form attached hereto as Exhibit E.D.
Appears in 1 contract
Opinion of Issuer’s Counsel. The Investor shall have received an opinion of Issuer’s counsel, dated the date of ClosingClosing Date, in the form attached hereto as Exhibit E.C. FINAL
Appears in 1 contract
Opinion of Issuer’s Counsel. The Investor Investors shall have received an opinion of Issuer’s counsel, dated the date of ClosingClosing Date, in the form attached hereto as of Exhibit E.D.
Appears in 1 contract
Samples: Stock Purchase Agreement (Biocryst Pharmaceuticals Inc)
Opinion of Issuer’s Counsel. The Investor shall have received an opinion of Issuer’s counsel, dated the date of Closing, in the form attached hereto as Exhibit E.D.
Appears in 1 contract
